{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T02:40:50Z","timestamp":1790995250450,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T00:00:00Z","timestamp":1535500800000},"content-version":"vor","delay-in-days":2341,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Portuguesa de Cardiologia"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.repc.2012.02.001","type":"journal-article","created":{"date-parts":[[2012,2,28]],"date-time":"2012-02-28T04:47:14Z","timestamp":1330404434000},"page":"265-273","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["CYP2C19*2 and prognosis after an acute coronary syndrome: Insights from a Portuguese center"],"prefix":"10.1016","volume":"31","author":[{"given":"Rog\u00e9rio","family":"Teixeira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Monteiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilberto","family":"Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o","family":"Pego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarida","family":"Louren\u00e7o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alda","family":"Reboredo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00edlvia","family":"Monteiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria J.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rio","family":"Freitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gra\u00e7a","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00eds A.","family":"Provid\u00eancia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.repc.2012.02.001_bib0005","first-page":"101","article-title":"Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity","volume":"115","author":"Gurbel","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.repc.2012.02.001_bib0010","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ahj.2007.04.014","article-title":"Clopidogrel nonresponsiveness in patients undergoing percutaneous coronary intervention with stenting: a systematic review and meta-analysis","volume":"154","author":"Snoep","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.repc.2012.02.001_bib0015","doi-asserted-by":"crossref","first-page":"27A","DOI":"10.1016\/j.amjcard.2008.11.020","article-title":"Variability in responsiveness to oral antiplatelet therapy","volume":"103","author":"Angiolillo","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.repc.2012.02.001_bib0020","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJMoa0808227","article-title":"Genetic determinants of response to clopidogrel and cardiovascular events","volume":"360","author":"Tabassome","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2012.02.001_bib0025","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0006-2952(92)90445-O","article-title":"Importance of hepatic metabolism in the antiaggregating activity of the thienopyridine clopidogrel","volume":"44","author":"Savi","year":"1992","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.repc.2012.02.001_bib0030","first-page":"682","article-title":"Regional assignment for the genes encoding human P450IIIA3 (CYP3) and P450IIC9 (CYP2C)","volume":"46","author":"Riddel","year":"1987","journal-title":"Cytogen Cell Genet"},{"key":"10.1016\/j.repc.2012.02.001_bib0035","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1111\/j.1538-7836.2007.02722.x","article-title":"Influence of CYP2C19 and CYP3A4 gene polymorphisms on clopidogrel responsiveness in healthy subjects","volume":"5","author":"Fontana","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.repc.2012.02.001_bib0040","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.amjcard.2007.11.065","article-title":"Effect of cytochrome P450 polymorphism on platelet reactivity after treatment with clopidogrel in acute coronary syndrome","volume":"101","author":"Frere","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.repc.2012.02.001_bib0045","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1097\/FPC.0b013e3282f1b2be","article-title":"Cytochrome P450 2C19 loss of function polymorphism, but not CYP3A4 IVS10+12G\/A and P2Y12 T744C polymorphisms, is associated with response variability to dual antiplatelet treatment in high-risk vascular patients","volume":"17","author":"Giusti","year":"2007","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.repc.2012.02.001_bib0050","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1001\/jama.2010.1543","article-title":"Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI","volume":"16","author":"Mega","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.repc.2012.02.001_bib0055","series-title":"Presented at: transcatheter cardiovascular therapeutics 2009; Sept. 21\u201315","article-title":"CHARISMA genomics. Plenary session XII. LBCT II","author":"Bhatt","year":"2009"},{"key":"10.1016\/j.repc.2012.02.001_bib0060","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ahj.2009.07.001","article-title":"The Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRA*CER) trial: study design and rationale","volume":"158","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.repc.2012.02.001_bib0065","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1160\/TH06-05-0242","article-title":"Multiple electrode aggregometry: a new device to measure platelet aggregation in whole blood","volume":"96","author":"Toth","year":"2006","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.repc.2012.02.001_bib0070","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1309\/AJCPTE3K1SGAPOIZ","article-title":"Assessment of platelet function on whole blood by multiple electrode aggregometry in high-risk patients with coronary artery disease receiving antiplatelet therapy","volume":"131","author":"Paniccia","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.repc.2012.02.001_bib0075","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1093\/nar\/gkm051","article-title":"Dual priming oligonucleotide system for the multiplex detection of respiratory viruses and SNP genotyping of CYP2C19 gene","volume":"35","author":"Chun","year":"2007","journal-title":"Nucl Acids Res"},{"key":"10.1016\/j.repc.2012.02.001_bib0080","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.phrs.2004.01.004","article-title":"Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian population","volume":"50","author":"Scordo","year":"2004","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.repc.2012.02.001_bib0085","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1053\/cp.1999.v66.100072001","article-title":"Low frequency of defective alleles of cytochrome P450 enzymes 2C19 and 2D6 in the Turkish population","volume":"66","author":"Aynacioglu","year":"1999","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.repc.2012.02.001_bib0090","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00008571-199702000-00008","article-title":"Frequencies of the defective CYP2C19 alleles responsible for the mephenytoin poor metabolizer phenotype in various Oriental, Caucasian, Saudi Arabian and American black populations","volume":"7","author":"Goldstein","year":"1997","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.repc.2012.02.001_bib0095","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s005350170029","article-title":"Genetic differences in CYP2C19 single nucleotide polymorphism among four Asians populations","volume":"36","author":"Yamada","year":"2001","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.repc.2012.02.001_bib0100","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1056\/NEJMoa0809171","article-title":"Cytochrome P-450 polymorphisms and response to clopidogrel","volume":"360","author":"Mega","year":"2009","journal-title":"NEJM"},{"key":"10.1016\/j.repc.2012.02.001_bib0105","doi-asserted-by":"crossref","first-page":"15419","DOI":"10.1016\/S0021-9258(17)40694-6","article-title":"The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans","volume":"269","author":"Morais","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.repc.2012.02.001_bib0110","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1111\/j.1538-7836.2007.02775.x","article-title":"Common polymorphisms of CYP2C19 and CYP2C9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not to prasugrel","volume":"5","author":"Brandt","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.repc.2012.02.001_bib0115","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1182\/blood-2006-04-013052","article-title":"Cytochrome P450 2C19 loss of function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjects","volume":"108","author":"Hulot","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.repc.2012.02.001_bib0120","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1469-1809.2007.00417.x","article-title":"Genetic polymorphism of CYP2C19 gene in the Stanislas cohort. A link with inflammation","volume":"72","author":"Bertrand-Thi\u00e9bault","year":"2008","journal-title":"Ann Hum Genet"},{"key":"10.1016\/j.repc.2012.02.001_bib0125","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0140-6736(08)61845-0","article-title":"Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study","volume":"373","author":"Collet","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.repc.2012.02.001_bib0130","first-page":"S598","article-title":"CYP2C19 genetic variants and clinical outcomes with clopidogrel: a collaborative meta-analysis","volume":"120","author":"Mega","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.repc.2012.02.001_bib0135","first-page":"A206","article-title":"Sequence variations in CYP metabolism genes and cardiovascular outcomes following treatment with clopidogrel: insights from the CLARITY-TIMI 28 genomic study","volume":"51","author":"Mega","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.repc.2012.02.001_bib0140","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.jacc.2007.12.056","article-title":"Cytochrome P450 2C19 681G>A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents","volume":"51","author":"Trenk","year":"2008","journal-title":"J Am Coll Cardiol"}],"container-title":["Revista Portuguesa de Cardiologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0870255112000340?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0870255112000340?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:59:43Z","timestamp":1760108383000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0870255112000340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0870255112000340"],"URL":"https:\/\/doi.org\/10.1016\/j.repc.2012.02.001","relation":{},"ISSN":["0870-2551"],"issn-type":[{"value":"0870-2551","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CYP2C19*2 and prognosis after an acute coronary syndrome: Insights from a Portuguese center","name":"articletitle","label":"Article Title"},{"value":"Revista Portuguesa de Cardiologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.repc.2012.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Sociedade Portuguesa de Cardiologia. Published by Elsevier Espa\u00f1a S.L. All rights reserved.","name":"copyright","label":"Copyright"}]}}